CLDN1 and breast cancer: For instance, ADAM15 catalytic activity was required for claudin-1-dependent regulation of growth and mobility of breast cancer cells (Mattern et al., 2019), but was not required for its role in promoting pathological neovascularization in a mouse model of oxygen-induced retinopathy (Maretzky et al., 2014).